Single-domain angiotensin I converting enzyme (kininase II): Characterization and properties

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1582-1589

  Deddish, Peter A ^b   Wang, Li Xiu ^b   Jackman, Herbert L ^b   Michel, Bruno ^a,b   Wang, Julia ^b   Skidgel, Randal A ^b   Erdös, Ervin G ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; KALLIKREIN; LISINOPRIL; PLASMIN; QUINAPRILAT; RAMIPRILAT; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; ENZYME ACTIVE SITE; ENZYME INHIBITION; GUINEA PIG; HYPERTENSION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BINDING SITES; BRADYKININ; DINITROFLUOROBENZENE; HUMANS; HYDROLYSIS; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; SUBSTRATE SPECIFICITY;

EID: 0030434802     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. AZIZI, M., ROUSSEAU, A., EZAN, E., GUYENE, T.-T., MICHELET, S., GROCNET, J.-M., LENFANT, M., CORVOL, P. AND MÉNARD, J.: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem-cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J. Clin. Invest. 97: 839-844, 1996.
2. BERNSTEIN, K. E., MARTIN, B. M., EDWARDS, A. S. AND BERNSTEIN, E. A.: Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J. Biol. Chem. 264: 11945-11951, 1989.
3. BOGDEN, A. E., CARDE, P., DESCHAMPS DE PAILLETTE, E., MOREAU, J.-P., TUBIANA, M. AND FRINDEL, E.: Amelioration of chemotherapy-induced toxicity by co-treatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Ann. NY Acad. Sci. 628: 126-139, 1991.
4. BRADFORD, M. M.: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-254, 1976.
5. BÜNNING, P., KLEEMANN, S. G. AND RIORDAN, J. F.: Essential residues in angiotensin converting enzyme: Modification with 1-fluoro-2,4-dinitrobenzene. Biochemistry 29: 10488-10492, 1990.
6. CHEN, Y.-N. P. AND RIORDAN, J. F.: Identification of essential tyrosine and lysine residues in angiotensin converting enzyme: Evidence for a single active site. Biochemistry 29: 10493-10498, 1990.
7. DEDDISH, P. A., WANG, J., MICHEL, B., MORRIS, P. W., DAVIDSON, N. O., SKIDGEL, R. A. AND E. G. ERDÖS.: Naturally occurring active N-domain of human angiotensin 1 converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 91: 7807-7811, 1994.
8. EHLERS, M. R. W., Fox, E. A., STRYDOM, D. J. AND RIORDAN, J. F.: Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 86: 7741-7745, 1989.
9. EHLERS, M. R. W. AND RIORDAN, J. F.: Angiotensin-converting enzyme. Biochemistry and molecular biology. In Hypertension: Pathophysiology, Diagnosis, and Management, ed. by J. H. Laragh and B. M. Brenner, 2nd ed., pp. 1217-1231, Raven Press, Ltd., New York, 1990.
10. EHLERS, M. R. W. AND RIORDAN, J. F.: Angiotensin converting enzyme: Zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 30: 7118-7126, 1991.
11. ERDÖS, E.G.: Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl Memorial Lecture. Hypertension 16: 363-370, 1990.
12. ERDÖS, E. G.: News about ACE, or, the separate lives of "Siamese Twin" domains (Editorial). J. Clin. Invest. 97: 588, 1996.
13. ERDÖS, E. G. AND YANG, H. Y. T.: Inactivation and potentiation of the effects of bradykinin. In Hypotensive Peptides, ed. by E. G. Erdös, N. Back and F. Sicuteri, Springer-Verlag, New York, pp. 235-250, 1966.
14. ERDÖS, E. G. AND GAFFORD, J. T.: Human converting enzyme. Clin. Exp. Hypertension A5: 1251-1262, 1983.
15. ERMAN, A., WINKLER, J., CHEN-GAL, B., RABINOV, M., ZELYKOVSKI, A., TADJER, S., SHMUELI, J., LEVI, E., AKBARY, A. AND ROSENFELD, J. B.: Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. J. Hypertension 9: 1057-1062, 1991.
16. GAVRAS, H.: Angiotensin converting enzyme inhibition and the heart. Hypertension 23: 813-818, 1994.
17. GAVRAS, I. AND GAVRAS, H.: ACE inhibitors: A decade of clinical experience. Hosp. Pract. 28:61-71, 1993.
18. 3H] Ramiprilat binding to the angiotensin converting enzyme in rat renal brushborder membranes: The effect of chloride. Eur. J. Pharmacol. 206: 203-209, 1991.
19. IGIĆ, R., NAKAJIMA, T., YEH, H. S. J., SORRELLS, K. AND ERDÖS E. G.: Kininases. In Pharmacology and the Future of Man. Proceedings of the 5th International Congress of Pharmacology, ed. by G. Acheson, pp. 307-319, Karger, Basel, 1973.
20. INOKUCHI, J.-I. AND NAGAMATSU, A.: Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme). Biochim. Biophys. Acta 662: 300-307, 1981.
21. IWATA, K., BLACKER, R., SOPPER, R. L. AND LAI, C.-Y.: Rabbit pulmonary angiotensin-converting enzyme: The NH2-terminal fragment with enzymatic activity and its formation from the native enzyme by NH40H treatment. Arch. Biochem. Biophys. 227: 188-201, 1983.
22. JACKMAN, H. L., TAN, F., TAMEI, H., BEURLING-HARBURY, C., LI X-Y., SKIDGEL, R. A. AND ERDÖS, E. G.: A peptidase in human platelets that deamidates tachykinins: Probable identity with the lysosomal "protective protein." J. Biol. Chem. 265: 11265-11272, 1990.
23. JASPARD, E., WEI, L. AND ALHENC-GELAS, F.: Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268: 9496-9503, 1993.
24. JASPARD, E. AND ALHENC-GELAS, F.: Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface. Biochem. Biophys. Res. Commun. 211: 528-534, 1995.
25. JOHNSON, A. R., SKIDGEL, R. A., GAFFORD, J. T. AND ERDÖS, E. G.: Enzymes in placental microvilli: Angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase ("enkephalinase"). Peptides 5: 789-796, 1984.
26. KASTURI, S., JABBAR, M. A., SEN, G. C. AND SEN, I.: Role of glycosylation in the biosynthesis and activity of rabbit testicular angiotensin converting enzyme. Biochemistry 33: 6228-6234, 1994.
27. KUMAR, R. S., KUSARI, J., ROY, S. N., SOFFER, R. L. AND SEN G. C.: Structure of testicular angiotensin-converting enzyme. A segmental mosaic enzyme. J. Biol. Chem. 264: 16754-16758, 1989.
28. KUMAR, R. S., THEKKUMKARA, T. J. AND SEN G. C.: The mRNAs encoding the two angiotensin converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites. J. Biol. Chem. 266: 3854-3862, 1991.
29. LATTION, A.-L., SOUBRIER, F., ALLEGRINI, J., HUBERT, C., CORVOL, P. AND ALHENCGELAS, F.: The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252: 99-104, 1989.
30. NAKAHARA, M.: Subunits of human plasma kininase II generated by plasma kallikrein. Biochem. Pharmacol. 27:1651-1657 1978.
31. NISHIMURA, K., YOSHIDA, N., HIWADA, K., UEDA, E. AND KOKUBU, T.: Purification and properties of angiotensin I-converting enzyme from human lung. Jpn. Circ. J. 42: 639-640, 1978.
32. ONDETTI, M. A.: From peptides to peptidases: A chronicle of drug discovery. Annu. Rev. Pharmacol. 34: 1-16, 1994.
33. OSHIMA, G., HIRAGA, Y., SHIRONO, K., OH-ISHI, S., SAKAKIBARA, S. AND KINOSHITA, T.: Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex. Experientia 41: 325-328, 1985.
34. PATCHETT, A. A. AND CORDES, E. H.: The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin converting enzyme. Adv. Enzymol. Relat. Areas Mol. Biol. 57: 1-84, 1985.
35. PERICH, R. B., JACKSON, B. AND JOHNSTON, C. I.: Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. Eur. J. Pharmacol. 266: 201-211, 1994.
36. RAMCHANDRAN, R., SEN, G. C., MISONO, K. AND SEN, I.: Regulated cleavage-secretion of the membrane-bound angiotensin converting enzyme. J. Biol. Chem. 269: 2125-2130, 1994.
37. ROUSSEAU, A., MICHAUD, A., CHAUVET, M.-T., LENFANT, M. AND CORVOL, P.: The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270: 3656-3661, 1995.
38. SKIDGEL, R. A.: Basic carboxypeptidases: Regulators of peptide hormone activity. Trends Pharmacol. Sci. 9: 299-304, 1988.
39. SKIDGEL, R. A. AND ERDÖS, E. G.: Novel activity of human angiotensin I converting enzyme: Release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 82: 1025-1029, 1985.
40. SKIDGEL, R. A. AND ERDÖS, E. G.: Biochemistry of angiotensin converting enzyme. In The Renin Angiotensin System, ed. by J. I. S. Robertson and M. G. Nicholls, vol. 1, pp. 10.1-10.10, Gower Medical Publishing, London, 1993.
41. SOUBRIER, F., ALHENC-GELAS, F., HUBERT, C., ALLEGRINI, J., JOHN, M., GREGEAR, G. AND CORVOL, P.: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. U.S.A. 85: 9386-9390, 1988.
42. SOUBRIER, F., HUBERT, C., TESTUT, P., NADAUD, S., ALHENC-GELAS, F. AND CORVOL, P.: Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene. J. Hypertension 11: 471-476, 1993a.
43. SOUBRIER, F., WEI, L., HUBERT, C., CLAUSER, E., ALHENC-GELAS, F. AND CORVOL, P.: Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J. Hypertension 11: 599-604, 1993b.
44. STEWART, T. A., WEARE, J. A. AND ERDÖS, E. G.: Purification and characterization of human converting enzyme (kininase II). Peptidea 2: 145-152, 1981.
45. STEWART, T. A., WEARE, J. A. AND ERDÖS, E. G.: Human peptidyl dipeptidase (converting enzyme, kininase II). Methods Enzymol. 80: 450-460, 1982.
46. WARD, P. E., SHERIDAN, M. A., HAMMON, K. J. AND ERDÖS, E. G.: Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine. Biochem. Pharmacol. 29: 1525-1529, 1980.
47. WEI, L., ALHENC-GELAS, F., CORVOL, P. AND CLAUSER, E.: The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266: 9002-9008, 1991.
48. WEI, L., CLAUSER, E., ALHENC-GELAS, F. AND CORVOL, P.: The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267: 13398-13405, 1992.
49. WYVRATT, M. J. AND PATCHETT, A. A.: Recent developments in the design of angiotensin-converting enzyme inhibitors. Med. Res. Rev. 5: 483-531, 1985.
50. YANG, H. Y. T. AND ERDÖS, E. G.: Second kininase in human blood plasma. Nature 215: 1402-1403, 1967.
51. YANG, H. Y. T., ERDÖS, E. G. AND LEVIN, Y.: A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta 214: 374-376, 1970.
52. YANG, H. Y. T., ERDÖS, E. G. AND LEVIN, Y.: Characterization of a dipeptide hydrolase (kininase II; angiotenain I converting enzyme). J. Pharmacol. Exp. Ther. 177: 291-300, 1971.